Taken together, lipolytically cleaved soluble Gpc4, the release of which into human serum is fostered by elevated insulin levels in response to insulin resistance and obesity, seems to operate as an insulin-sensitizing adipokine and to counteract impaired insulin signaling via a feedback loop. The gene discussed is INS; the disease is obesity disorder.